期刊文献+

利培酮治疗精神分裂症临床观察 被引量:14

Clinical observation on schizophrenic patients treated with risperidone
在线阅读 下载PDF
导出
摘要 目的 :研究利培酮治疗精神分裂症的疗效与副反应。 方法 :7所医院共计收集精神分裂症患者 90 4例 ,其中以利培酮治疗者 40 5例 ,其余为以氯氮平、氟哌啶醇、氯丙嗪或舒必利治疗的对照病例 ,使用阳性症状与阴性症状量表 (PANSS) ,简明精神病评定量表 (BPRS) ,阴性症状评定量表(SANS) ,阳性症状评定量表 (SAPS) ,临床疗效总评量表 (CGI)和副反应量表 (TESS)等量表进行观察。 结果 :利培酮治疗精神分裂症有肯定疗效 ,有的与对照组相仿 ,有的超过对照组。副反应一般较轻。对睡眠影响较少 ,小剂量 (4 m g/ d左右 )疗效并不降低 ,而副反应更少。 结论 :利培酮可作为治疗精神分裂症的一线药物 ,可用于首发、难治病例、预防复发和青少年病例等 ,对维护和提高患者的生活质量较好。 Objective:To study the efficacy and side effects of risperidone in treating schizophrenic patients. Method:904 cases of schizphrenic patients were collected from 7 mental hospitals.Among them,405 cases were treated with risperidone,the others who received clozapine, haloperidol, chlorpromazine or sulpiride as controls.Rating scales such as PANSS, BPRS, SANS,SAPS, CGI,GQOLI,TESS and ESRS were used as tools of evaluation Results:Risperidone had definitely similar or better therapeutic effect for schizophrenia than the other drugs. Side effects were mild in general Risperidone had less influence on sleep.A small dosage (about 4 mg/d) had the same effect but produced less side effects. Conclusion: Risperidone could be an option of first line treatment for schizophrenia.It could be used to treat or prevent the relapse of first onset patients, refractory patients, and young patients, etc. Risperidone may be useful in maintaining and promoting life quality of schizophrenic patients.
出处 《临床精神医学杂志》 2001年第6期325-328,共4页 Journal of Clinical Psychiatry
关键词 精神分裂症 利培酮 副反应 睡眠障碍 治疗 Schizophrenia Risperidone Effect Side effect Sleep disturbance
  • 相关文献

参考文献6

二级参考文献3

共引文献378

同被引文献24

  • 1梁峻铭,陈大坤.阿立哌唑与氟哌啶醇治疗精神分裂症对照研究[J].中国药业,2005,14(6):82-82. 被引量:14
  • 2于欣,侯也之,舒良,王秀玲,李冰,刘卫红,林凯,杨顺才,宋丽华,廖安燕,谢家康,贾宏晓,张继志.利培酮治疗精神分裂症的开放性临床验证[J].中华精神科杂志,1997,30(2):79-82. 被引量:330
  • 3中华医学会精神科分会.中国精神障碍分类与诊断标准(CCMD-3)[M](第3版)[M].济南:山东科学技术出版社,2001.160-162.
  • 4Anthony D,Nick Cpatel,Lynn C.Aripiprazole:a comprehensive review of its pharmacology,clinical efficacy,and tolerability[J].Clinical Therapeutics,2004,(26):649-666.
  • 5Stepshen RM,Robert DM,Elyse S,et al.Aripiprazole in the treatment of schizophrenia:safety and tolerability in short-term,placebo-controlled trials[J].Schizophrenia Research,2003,61(2):123-136.
  • 6中华医学会精神科分会..中国精神障碍分类与诊断标准(CCMD-3)[M].第3版..济南:山东科学技术出版社,,2001:5....
  • 7Hertling I, Philipp M, Dvorak A, et al. Flupeothixol versus risperidone: subjective quality of life as an important factor for compliance in chronic schizophrenic patients[ J]. Neuropsyehobiology ,2003 ;47( 1 ) :37-46.
  • 8Harrison TS, Goa KK Long-acting risperidone: a review of its use in schizophrenia[ J ]. CNS Drugs,2004 ; 18 (2) : 113-32.
  • 9Bilder RM, Goldman RS, Volavka J,et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder[ J]. Am J Psychiatry ,2002 ; 159 (6) :1018-28.
  • 10王锋,江永华,田新华,张伟,秦阳.氯氮平合并拉莫三嗪治疗难治性分裂症的对照研究[J].精神医学杂志,2008,21(1):39-41. 被引量:11

引证文献14

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部